Trial
NCT02988297
Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Revalesio Corporation
Collaborators
—
Condition
Amyotrophic Lateral Sclerosis
Intervention
RNS60
Why stopped
Withdrawn prior to initiation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-16